Your browser doesn't support javascript.
loading
Hypovitaminosis D and cardiovascular outcomes: A systematic review and meta-analysis.
Jaiswal, Vikash; Ishak, Angela; Peng Ang, Song; Babu Pokhrel, Nishan; Shama, Nishat; Lnu, Kriti; Susan Varghese, Jeffy; Storozhenko, Tatyana; Ee Chia, Jia; Naz, Sidra; Sharma, Prachi; Jaiswal, Akash.
  • Jaiswal V; AMA School of Medicine, Makati, Philippines.
  • Ishak A; European University Cyprus, School of Medicine, Nicosia, Cyprus.
  • Peng Ang S; School of Medicine, International Medical University, Kuala Lumpur, Malaysia.
  • Babu Pokhrel N; Tribhuvan University Institute of Medicine, Maharajgunj, Kathmandu, Nepal.
  • Shama N; Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM) General Hospital, Dhaka, Bangladesh.
  • Lnu K; Department of Internal Medicine, UPMC Harrisburg, PA, USA.
  • Susan Varghese J; Department of Cardiology, St. John's Medical College, Bangalore, India.
  • Storozhenko T; Government Institution "L.T. Malaya Therapy National Institute NAMSU", Kharkiv, Ukraine.
  • Ee Chia J; School of Medicine, International Medical University, Kuala Lumpur, Malaysia.
  • Naz S; BIDMC, Harvard Medical School, USA.
  • Sharma P; Department of Cardiology, King George's Medical University, Lucknow, India.
  • Jaiswal A; Department of Geriatric Medicine, All India Institute of Medical Science, New Delhi, India.
Int J Cardiol Heart Vasc ; 40: 101019, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35463916
ABSTRACT

Background:

The relation between blood vitamin D levels and the risk of cardiovascular outcomes is debatable. To our knowledge this is the first comparative meta-analysis of more than 100,000 patients' data with the aim to inspect the relevance of low vitamin D levels with adverse cardiovascular events.

Methods:

Online databases including PubMed, Embase and Cochrane Central were queried to compare the cardiovascular outcomes among hypovitaminosis D (HVD) and control group. The outcomes assessed included differences in major adverse cardiovascular events (MACE), mortality, myocardial infarction, and heart failure. Unadjusted odds ratios (OR) were calculated using a random-effect model with a 95% confidence interval (CI) and P less than 0.05 as a statistical significance.

Results:

A total of 8 studies including 426,039 patients were included in this analysis. HVD group was associated with a higher incidence of MACE (OR 1.92, 95% CI 1.24 to 2.98, p = 0.003), while there was no significant association of HVD and all-cause mortality (OR 1.77, 95% CI 0.75 to 4.17, p = 0.19), risk of myocardial infarction (OR 0.69, 95% CI 0.39 to 1.24, p = 0.22), and heart failure (OR 1.20, 95% CI 0.34 to 4.25, p = 0.78).

Conclusions:

This meta-analysis suggested that low blood levels of vitamin D are associated with MACE, but no such difference in all-cause mortality, myocardial infarction or heart failure was observed. Appropriate supplementation of vitamin D in selected populations might be cardioprotective in nature and warrants extensive trials.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Año: 2022 Tipo del documento: Article